Flu and pneumococcal immunisations in HIV-infected children: Methodological quality of current recommendations

BMJ Quality and Safety

Volumn 20, Issue 5, 2011, Pages 432-439

  Giannattasio, Antonietta ^a   Lo Vecchio, Andrea ^a   Albano, Fabio ^a   Giacomet, Vania ^b   Barbarino, Alessandro ^a   Guarino, Alfredo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ARTICLE; CHECKLIST; CHILD; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONSENSUS; EMBASE; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; MEDLINE; METHODOLOGY; PRACTICE GUIDELINE; RISK BENEFIT ANALYSIS; SELF EVALUATION; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; HIV INFECTIONS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE;

EID: 79957991410     PISSN: 20445415     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmjqs.2010.047316     Document Type: Article

References (40)

1. Overton ET. An overview of vaccinations in HIV. Curr HIV/AIDS Rep 2007;4:105-13. (Pubitemid 47493050)
2. Mofenson LM, Brady MT, Danner SP, et al; Centers for Disease Control and Prevention; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America; Paediatric Infectious Diseases Society; American Academy of Pediatrics. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Paediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep 2009;58:1-166.
3. Lin JC, Nichol KL. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 2001;161:441-6. (Pubitemid 32116562)
4. Klein MB, Lu Y, DelBalso L, et al. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clin Infect Dis 2007;45:234-40. (Pubitemid 47041016)
5. Levine OS, Farley M, Harrison LH, et al. Risk factors for invasive pneumococcal disease in children: a population-based case - control study in North America. Pediatrics 1999;103:E28.
6. Cartwright K. Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management. Eur J Pediatr 2002;161:188-95. (Pubitemid 34253335)
7. Anon. Piano Sanitario Nazionale. 2005-2008. http://www.ministerosalute. it/resources/static/psn/documenti/psn-2005-2008.PDF.
8. Fiore AE, Shay DK, Broder K, et al; Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009;58:1-52.
9. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2008;34:1-46. http://www.phac-aspc.gc.ca/publicat/ ccdr-rmtc/08vol34/acs-3/indexeng.php.
10. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999;281:1900-5. (Pubitemid 29242803)
11. Cluzeau FA, Littlejohns P, Grimshaw JM, et al. Development and application of a generic methodology to assess the quality of clinical guidelines. Int J Qual Health Care 1999;11:21-8. (Pubitemid 29100340)
12. Boluyt N, Lincke CR, Offringa M. Quality of evidence-based pediatric guidelines. Pediatrics 2005;115:1378-91. (Pubitemid 43843246)
13. Lopez-Olivo MA, Kallen MA, Ortiz Z, et al. Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review. Arthritis Rheum 2008;59:1625-38.
14. Potting C, Mistiaen P, Poot E, et al. A review of quality assessment of the methodology used in guidelines and systematic reviews on oral mucositis. J Clin Nurs 2009;18:3-12.
15. Villari P, Manzoli L, Boccia A. Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis. Vaccine 2004;22:3475-86. (Pubitemid 39078767)
16. Campbell F, Dickinson HO, Cook JV, et al. Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall. BMC Health Serv Res 2006;6:47.
17. Field M, Lohr K. Institute of Medicine Committee to Advice the Public Health Service on Clinical Practice Guidelines. Clinical Practice Guidelines: Directions for a New Program. Washington (DC): National Academy Press, 1990.
18. Institute of Medicine. Guidelines for Clinical Practice: From Development to Use. Washington, DC: National Academy Press, 1992.
19. The Cochrane Collaboration. Glossary of Cochrane Collaboration and research terms. http://www.cochrane.org/resources/glossary.htm.
20. AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003;12:18-23.
21. Scottish Intercollegiate Guidelines Network. SIGN 50. A Guideline Developer's Handbook. Edinburgh: SIGN, 2008. http://www.sign.ac.uk/guidelines/ fulltext/50/index.html.
22. Randolph JJ. Free-Marginal Multirater Kappa: an alternative to Fleiss'Fixed Marginal Multirater Kappa. Joensuu, Finland: Presented at the Joensuu University Learning and Instruction Symposium 2005, 2005. http://www.eric.ed.gov/ERICDocs/data/ericdocs2sql/content-storage-01/0000019b/ 80/1b/c3/27.pdf.
23. Anema A, Mills E, Montaner J, et al. Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis. HIV Med 2008;9:57-61.
24. Zanetti AR, Amendola A, Besana S, et al. Safety and immunogenicity of influenza vaccination in individuals infected with HIV. Vaccine 2002;(20 Suppl 5):B29-32.
25. Neuzil KM, Griffin MR, Schaffner W. Influenza vaccine: issues and opportunities. Infect Dis Clin North Am 2001;15:123-41. (Pubitemid 32268117)
26. Brydak LB, Machala M. Humoral immune response to influenza vaccination in patients from high risk groups. Drugs 2000;60:35-53. (Pubitemid 30601315)
27. Destefano F, Pfeifer D, Nohynek H. Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data. Bull World Health Organ 2008;86:373-80. (Pubitemid 351694318)
28. Bliss SJ, O'Brien KL, Janoff EN, et al. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis 2008;8:67-80. (Pubitemid 351620930)
29. Spencer DC. Preventing bacterial disease in the HIV-infected of sub-Saharan Africa: the role of cotrimoxazole and the pneumococcal vaccines. Curr HIV/AIDS Rep 2007;4:141-6. (Pubitemid 47493055)
30. Pai VB, Heyneman CA, Erramouspe J. Conjugated heptavalent pneumococcal vaccine. Ann Pharmacother 2002;36:1403-13. (Pubitemid 34925278)
31. Overturf GD. American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 2000;106:367-76.
32. Anon. American Academy of Pediatrics, Committee on Infectious Diseases. Policy Statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000;106:362-6.
33. New York State Department of Health. Immunologic Considerations in HIV-Infected Children. New York: State Department of Health, 2003:20. http://www.hivguidelines.org/GuidelineDocuments/p-imm.pdf.
34. Geretti AM. British HIV Association Guidelines for Immunization of HIV infected Adults 2008. HIV Medicine 2008. http://www.medscape.com/viewarticle/ 583957.
35. European Centre for Disease Prevention and Control (ECDC). Priority Risk Groups for Influenza Vaccination. Stockholm, 2008. http://www.ecdc.europa.eu/en/ publications/Publications/0808-GUI-Priority-Risk-Groups-for-Influenza- Vaccination.pdf.
36. New York State Department of Health AIDS Institute. Prevention of Secondary Disease: Preventive Medicine, 2006. http://www.hivguidelines.org/ GuideLine.aspx?pageID=260&guideLineID=86.
37. Skiest DJ, Machala T. Comparison of the effects of acute influenza infection and Influenza vaccination on HIV viral load and CD4 cell counts. J Clin Virol 2003;26:307-15. (Pubitemid 36294108)
38. Burgers JS, Fervers B, Haugh M, et al. International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument. J Clin Oncol 2004;22:2000-7. (Pubitemid 41095193)
39. Watine J, Friedberg B, Nagy E, et al. Conflict between guideline methodological quality and recommendation validity: a potential problem for practitioners. Clin Chem 2006;52:65-72. (Pubitemid 43032468)
40. Brouwers MC, Kho ME, Browman GP, et al; AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting, and evaluation in health care. Prev Med 2010;51:421-4.